| Quality control of positron emission tomography radiopharmaceuticals: An institutional experience J Shukla, R Vatsa, N Garg, P Bhusari, A Watts, BR Mittal Indian Journal of Nuclear Medicine 28 (4), 200-206, 2013 | 29 | 2013 |
| Integrin αvβ3 as a Promising Target to Image Neoangiogenesis Using In-House Generator-Produced Positron Emitter 68Ga-Labeled DOTA-Arginine-Glycine … R Vatsa, P Bhusari, S Kumar, S Chakraborty, A Dash, G Singh, ... Cancer Biotherapy and Radiopharmaceuticals 30 (5), 217-224, 2015 | 20 | 2015 |
| 225Ac-PSMA-617 radioligand posttherapy imaging in metastatic castrate-resistant prostate cancer patient using 3 photopeaks R Vatsa, A Sood, SK Vadi, CK Das, K Kaur, M Parmar, BR Mittal Clinical Nuclear Medicine 45 (6), 437-438, 2020 | 15 | 2020 |
| 99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes BR Mittal, A Sood, J Shukla, R Vatsa, P Bhusari, R Shree, S Mehta, ... Nuclear medicine communications 39 (4), 312-318, 2018 | 12 | 2018 |
| Usefulness of 68Ga-DOTA-RGD (αvβ3) PET/CT imaging in thyroglobulin elevation with negative iodine scintigraphy R Vatsa, J Shykla, BR Mittal, P Bhusari, A Sood, RK Basher, ... Clinical Nuclear Medicine 42 (6), 471-472, 2017 | 8 | 2017 |
| Breast cancer imaging with PET based radiopharmaceuticals other than 18F-FDG R Vatsa, SS Singh, AG Ashwathanarayana, R Kumar, N Rana, J Shukla, ... Clinical Nuclear Medicine 45 (2), e72-e76, 2020 | 4 | 2020 |
| A comparison of angiogenesis and glycolytic imaging in patients with clinical suspected locally advanced breast cancer R Vatsa, AG Ashwathanarayana, G Singh, AJ Kavanal, S Kumar, N Rana, ... Clinical Nuclear Medicine 44 (8), e479-e483, 2019 | 3 | 2019 |
| In-house preparation and quality control of Tc99m TRODAT 1 for diagnostic single-photon emission computed tomography/computed tomography imaging in parkinson's disease R Vatsa, J Shukla, BR Mittal, A Sood, RK Joshi, K Palarwal, P Bhusari, ... Indian Journal of Nuclear Medicine 32 (4), 266-270, 2017 | 1 | 2017 |
| Practical consideration regarding stability of F-18 2-deoxy-2-[18F] fluoro-D-glucose, procured from a distant commercial production site R Vatsa, H Singh, N Rana, R Kumar, BR Mittal Indian Journal of Nuclear Medicine 35 (1), 89-90, 2020 | | 2020 |
| Troubleshooting for F-18 fluorocholine synthesis: An institutional experience R Vatsa, RK Joshi, J Shukla, BR Mittal Indian Journal of Nuclear Medicine 33 (4), 355-358, 2018 | | 2018 |
Jaya ShuklaProfessor, PGIMER Chandigarh IndiaVerified email at pgimer.edu.in
